IGF1 and Miyoshi myopathy: Thus, we hypothesized that IGF-1 might exert protective effects against ABT-analogous and that the IGF-1R inhibitor picropodophyllin (PPP) might potentiate the efficacy of this class of BH3 mimetics in MM.